# RRM-002-CYBER-PHARMA — Gate Q Certification

**Certification date:** 2026-09-28  
**QA Lead:** SOL / JARVIS  
**Module:** RRM-002-CYBER-PHARMA — Ledger Truth  
**Repository:** `cyber-pharma-dev-v1-phase-3`  
**QA branch:** `qa/phase-3-rrm002`  
**Code baseline:** `1cd6e465ebbfeb0842738fcbab1ffbe65e2dbe6b`  
**Certified candidate:** `34e6fb6fd8c4e5c6610f4b0f49177abcb6cc0731`  
**Evidence HEAD:** `cb9f7b7e707f206f019b40c7079487888cc14d03`  

## Verdict

**GATE Q: PASS**

RRM-002 is certified against the immutable candidate above. No product defect, release blocker, or RRM-002 repair requirement was found. The module may proceed to bounded documentation/evidence cleanup and Architect closeout. No additional product test run is required unless the candidate changes or closeout touches product/configuration files.

## Certified behavior

- The Summary disclosure independently derives to **$20.27** from the candidate fixtures.
- The disclosure renders only for a matching, settled Summary/KPI filter pair with a rounded gap of at least one cent.
- Zero, sub-cent, negative, pending, rejected, mixed, and stale states correctly hide the disclosure.
- A real-browser slow-Summary race did not revive stale disclosure text after the filters changed.
- Repeated Clear Filters actions restored the correct unfiltered disclosure without creating duplicate or stale output.
- Authenticated ADMIN and MEMBER sessions completed the required browser matrix across desktop, 375px, light, dark, default, and named-PBM states.
- All named-PBM states hid the disclosure; all default states showed the exact $20.27 copy.
- Other tabs did not render the Summary disclosure, and returning to Summary restored it.
- The audit correction is limited to the ruled E-12 comment; all 150 fixture rows and all money values remain byte-identical to baseline.
- Protected service, type, wrapper, and preserved product paths remain unchanged.

## Independent board

- Blank-environment production build: PASS — 17 routes.
- Placeholder-environment production build: PASS — 17 routes.
- TypeScript: PASS — 0 errors.
- ESLint: PASS — 0 errors, 35 warnings.
- Jest: PASS — 31/31 suites, 144/144 tests, 0 skipped, pending, or todo.
- QA edge tests: PASS — 2/2.
- Authenticated browser matrix: PASS — 16/16 Summary states.
- Evidence security scan: PASS — no credentials, tokens, cookies, environment values, or reusable browser state included.

## Findings and adjudication

- **Product defects:** 0.
- **Blocking findings:** 0.
- **Repair rounds required:** 0.
- **QA-F01 — replica authentication unavailable:** CLOSED as a resolved Environment / Setup Issue. The free replica was paused and its reusable identities had drifted. The Director authorized the base CyberPharma authentication environment for the read-only browser walk. This did not expose an RRM-002 product defect.
- **QA-O01 — broad generated-type search hit:** informational search-context observation only; not a product finding.
- The QA helper picker obstruction was repaired only inside disposable QA tooling and did not alter the product.
- AC-402's historical clean-tree moment cannot be recreated after the fact. Contemporaneous Engineering records, exact parentage, the docs-only successor diff, and the independently observed clean tracked tree provide sufficient evidence for this module. This is an evidence limitation, not a failed criterion.

## Scope protection

The following ruled/deferred money topics remain outside RRM-002 and were not charged as defects: Rule-3 fixture drift, positive-only aggregates, negative-owed presentation, MAC/NADAC vocabulary, federal math, and status vocabulary. Their existing owners and future gates remain unchanged.

## Evidence basis

Certification is based on the frozen acceptance specification and rulings plus independent static, fixture, build, regression, race, and authenticated-browser evidence. The retained package contains 21 screenshots, three safe traces, raw result records, an AC evidence matrix, and an artifact inventory. The evidence archive passed integrity inspection and contains no reusable authentication material.

## Boundary of this certificate

This is **Gate Q**, not Gate D. It certifies the local pre-deployment candidate only. It does not certify a deployed revision, production configuration, future database math, or any later module.

## Release recommendation

Proceed with the normal closeout chain:

1. Architect issues one bounded closeout prompt.
2. Engineer performs documentation-only closeout and QA-lane cleanup without changing product/configuration files.
3. Final artifact inventory and cleanup report are written, and this certificate is placed at `agent_docs/ACTIONS/RRM-002-CYBER-PHARMA/QA/QA_CERTIFICATION.md`.
4. QA Lead's append-only campaign-journal entry is placed without editing the Architect's seat.
5. Director reviews the final diff, commits, merges `qa/phase-3-rrm002` to `main`, and pushes.

If any product/configuration byte changes during closeout, this certification is invalidated and the affected checks must be rerun against a newly pinned candidate.

